Trinbelimab | m-entrepreneurship.com

Product Name :
Trinbelimab

Search keywords :
Trinbelimab

drugId :
null

Target Vo:
Blood group Rh(D) polypeptide

Target Vo Short Name :
RHD

Moa_Name:
Blood group Rh(D) polypeptide inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Lokmanya Tilak Municipal General Hospital, Mumbai

Active Company_Name :
Lokmanya Tilak Municipal General Hospital, Mumbai

Active Indication_Name:
Erythroblastosis, Fetal

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cleaved-Caspase 9 Antibody Formula
Intetumumab Purity
Fibronectin Antibody (YA762): Fibronectin Antibody (YA762) is a non-conjugated and Mouse origined monoclonal antibody about 272 kDa, targeting to Fibronectin (1E2). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts